Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Clinical trial NCT07039669 · RECRUITING

Trial details

NCT number: NCT07039669
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive (COPD)

Start date: 2025-07-16
Primary completion: 2028-09-01
Enrollment: 594

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.